Skip to main content
. Author manuscript; available in PMC: 2019 Jul 8.
Published in final edited form as: Clin Exp Ophthalmol. 2018 Nov 13;47(2):193–200. doi: 10.1111/ceo.13382

TABLE 1.

American Joint Committee on Cancer (AJCC) 7th and 8th edition staging criteria for ocular surface squamous neoplasiaa (8th edition updates to the 7th edition are bolded)

Tumour (T) category Tumour criteria (7th edition) Tumour criteria (8th edition)
TX Primary tumour cannot be assessed Primary tumour cannot be assessed
TO No evidence of primary tumour No evidence of primary tumour
Tis Carcinoma in situ; includes dysplasia, collectively referred to as conjunctival intraepithelial neoplasia Carcinoma in situ; includes dysplasia, collectively referred to as conjunctival intraepithelial neoplasia
T1 Tumour ≤5 mm in greatest dimension Tumour (≤5 mm in greatest dimension) invades through the conjunctival basement membrane without invasion of adjacent structures (listed in T3)
T2 Tumour >5 mm in greatest dimension, without invasion of adjacent structures (listed in T3) Tumour (>5 mm in greatest dimension) invades through the conjunctival basement membrane without invasion of adjacent structures (listed in T3)
T3 Tumour invades adjacent structures (excluding the orbit), including cornea, intraocular structures, forniceal conjunctiva, palpebral conjunctiva, tarsal conjunctiva, lacrimal punctum, canaliculi, plica, caruncle, anterior or posterior eyelid lamella, and/or eyelid margin Tumour invades adjacent structures (excluding the orbit),
including cornea, intraocular structures, forniceal conjunctiva, palpebral conjunctiva, tarsal conjunctiva, lacrimal punctum, canaliculi, plica, caruncle, anterior or posterior eyelid lamella, and/or eyelid margin
T4 Tumour invades the orbit with or without further extension Tumour invades the orbit with or without further extension
a

Modified from AJCC Staging Manual.1,2